131 Results

People

  1. Allison
    Allison
  2. Houghton
    Houghton
  3. Perales
    Perales
  4. Old
    Old
  5. Wolchok
    Wolchok
  6. Rudensky
    Rudensky
  7. Pamer
    Pamer
  8. Quezada
    Quezada
  9. Van Den Brink
    Van Den Brink
  10. Gnjatic
    Gnjatic

Groups

  1. Department of Medicine (61)
  2. GSK Faculty (57)
  3. Sloan Kettering Institute Faculty (49)
  4. Hematologic Malignancies, Division of (42)
  5. Center for Hematologic Malignancies (40)
  6. Immunology Program Faculty (37)
  7. Sloan Kettering Institute Postdocs (25)
  8. Solid Tumor Oncology Division (22)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (20)
  10. Hematologic Malignancies Research (18)
  1. "effector cell"
Formats
  1. Journal Article (111)
  2. Review (13)
  3. Editorial (3)
  4. Guidelines (2)
  5. Conference Paper (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (61)
  2. GSK Faculty (57)
  3. Sloan Kettering Institute Faculty (49)
  4. Hematologic Malignancies, Division of (42)
  5. Center for Hematologic Malignancies (40)
  6. Immunology Program Faculty (37)

More Groups

People
  1. Alan Houghton (11)
  2. James Allison (11)
  3. Jedd Wolchok (11)
  4. Miguel-Angel Perales (10)
  5. Lloyd Old (9)
  6. Michel Sadelain (7)

More People

Years
  1. 2025 (3)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publications
  1. Journal of Immunology (12)
  2. Blood (8)
  3. Journal of Experimental Medicine (7)
  4. Proceedings of the National Academy of Sciences of the United States of America (7)
  5. Nature (5)
  6. Immunological Reviews (4)

More Publications

Publishers
  1. Nature Publishing Group (22)
  2. The American Association of Immunologists, Inc (12)
  3. Elsevier Inc. (11)
  4. American Society of Hematology (10)
  5. National Academy of Sciences (7)
  6. Rockefeller University Press (7)

More Publishers

Results (131)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paving the road for chimeric antigen receptor T cells: American Society for Transplantation and Cellular Therapy 80/20 task force consensus on challenges and solutions to improving efficiency of clinical center certification and maintenance of operations for commercially approved immune effector cell therapies
    Journal Article

    Nikiforow, S.; Frigault, M. J.; Frey, N. V.; Gardner, R. A.; Komanduri, K. V.; Perales, M. A.; Kebriaei, P.; Warkentin, P. I.; Pasquini, M.; Aho, J. L.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
    Review

    Cichocki, F.; van der Stegen, S. J. C.; Miller, J. S.
    Blood (2023)

    Fulltext@MSK | Save
  • Bispecific antibodies for the treatment of B-cell lymphoma: Promises, unknowns, and opportunities
    Review

    Falchi, L.; Vardhana, S. A.; Salles, G. A.
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world evidence of axicabtagene ciloleucel for the treatment of Large B cell lymphoma in the United States
    Journal Article

    Jacobson, C. A.; Locke, F. L.; Ma, L.; Asubonteng, J.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobadi, A.; Miklos, D. B.; Lin, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Considerations for immune effector cell therapy collections: A white paper from the American Society for Apheresis
    Journal Article

    Liu, H. D.; Su, L.; Winters, J. L.; Thibodeaux, S. R.; Park, Y. A.; Wu, Y.; Schwartz, J.; Zubair, A. C.; Schneiderman, J.; Gupta, G. K.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
    Journal Article

    Lévy, R.; Langlais, D.; Béziat, V.; Rapaport, F.; Rao, G.; Lazarov, T.; Bourgey, M.; Zhou, Y. J.; Briand, C.; Moriya, K.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • The advent of CAR T-cell therapy for lymphoproliferative neoplasms: Integrating research into clinical practice
    Review

    Cerrano, M.; Ruella, M.; Perales, M. A.; Vitale, C.; Faraci, D. G.; Giaccone, L.; Coscia, M.; Maloy, M.; Sanchez-Escamilla, M.; Elsabah, H.; more...
    Frontiers in Immunology (2020)

    Fulltext@MSK | Save
  • Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy
    Review

    Lambin, P.; Lieverse, R. I. Y.; Eckert, F.; Marcus, D.; Oberije, C.; van der Wiel, A. M. A.; Guha, C.; Dubois, L. J.; Deasy, J. O.
    Seminars in Radiation Oncology (2020)

    Fulltext@MSK | Save
  • Enforcing T cell innocence: Inhibitory signaling on T cells maintains "naïvety" to self-antigen
    Editorial

    Brown, C.; Rudensky, A. Y.
    Science (2020)

    Fulltext@MSK | Save
  • Robust CD4(+) T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin
    Journal Article

    Politikos, I.; Lavery, J. A.; Hilden, P.; Cho, C.; Borrill, T.; Maloy, M. A.; Giralt, S. A.; van den Brink, M. R. M.; Perales, M. A.; Barker, J. N.
    Blood Advances (2020)

    Fulltext@MSK | Save